Homozygous mutations in genes encoding HFE, transferrin receptor 2 and hemojuvelin (HJV) can result decreased hepcidin expression and the development of hemochromatosis, indicating that these proteins act as positive regulators of hepcidin synthesis. This evidence concerns the gene HJV and hemochromatosis type 1.